Couvineau Alain, Lacapere Jean-Jacques, Tan Yossan-Var, Rouyer-Fessard Christiane, Nicole Pascal, Laburthe Marc
INSERM U410 Neuroendocrinologie et Biologie Cellulaire Digestives, Institut National de la Santé et de la Recherche Médicale, Faculté de Médecine Xavier Bichat, F-75018 Paris, France.
J Biol Chem. 2003 Jul 4;278(27):24759-66. doi: 10.1074/jbc.M301916200. Epub 2003 Apr 10.
The VPAC1 receptor mediates the action of two neuropeptides, vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating peptide. It is a class II G protein-coupled receptor-activating adenylyl cyclase (AC). The role of the N-terminal extracellular domain of hVPAC1 receptor for VIP binding is now established (Laburthe, M., Couvineau, A. and Marie, J. C. (2002) Recept. Channels 8, 137-153), but nothing is known regarding the cytoplasmic domains responsible for AC activation. Here, we constructed a large series of mutants by substituting amino acids with alanine in the intracellular loops (IL) 1, 2, and 3 and proximal C-terminal tail of the receptor. The mutation of 40 amino acids followed by expression of mutants in chinese hamster ovary cells showed the following. (i) Mutations IL1 result in the absence of expression of mutants, suggesting a role of this loop in receptor folding. (ii) All residues of IL2 can be mutated without alteration of receptor expression and AC response to VIP. (iii) Mutation of residues IL3 points to the specific role of lysine 322 in the efficacy of the stimulation of AC activity by VIP. This efficacy is reduced by 50% in the K322A mutant. (iv) The proximal C-terminal tail is equipped with another important amino acid since mutation of glutamic acid 394 reduces AC response by 50%. The double mutant K322A/E394A exhibits a drastic reduction of >85% in the efficacy of VIP in stimulating AC activity in membranes and cAMP response in intact cells without alteration of receptor expression or affinity for VIP. These data highlight the role of charged residues in IL3 and the proximal C-terminal tail of hVPAC1 receptor for agonist-induced AC activation. Because these charged residues are absolutely conserved in class II receptors for peptides, which are all mediating AC activation, they may play a general role in coupling of class II receptors with the Gs protein.
血管活性肠肽受体1(VPAC1受体)介导两种神经肽——血管活性肠肽(VIP)和垂体腺苷酸环化酶激活肽的作用。它是一种II类G蛋白偶联受体,可激活腺苷酸环化酶(AC)。目前已明确人VPAC1受体N端胞外结构域在VIP结合中的作用(Laburthe, M., Couvineau, A.和Marie, J. C.(2002年)《受体与通道》8卷,137 - 153页),但对于负责激活AC的胞质结构域却一无所知。在此,我们通过将受体细胞内环(IL)1、2、3及近端C末端尾巴中的氨基酸用丙氨酸替代,构建了一系列大量的突变体。对40个氨基酸进行突变,随后在中国仓鼠卵巢细胞中表达这些突变体,结果如下:(i)IL1环突变导致突变体无法表达,表明该环在受体折叠中起作用。(ii)IL2的所有残基均可突变,而不改变受体表达及AC对VIP的反应。(iii)IL3残基的突变表明赖氨酸322在VIP刺激AC活性的效能中具有特定作用。在K322A突变体中,这种效能降低了50%。(iv)近端C末端尾巴含有另一个重要氨基酸,因为谷氨酸394突变会使AC反应降低50%。双突变体K322A/E394A在刺激膜中AC活性及完整细胞中cAMP反应时,VIP的效能急剧降低>85%,而不改变受体表达或对VIP的亲和力。这些数据突出了hVPAC1受体IL3及近端C末端尾巴中带电荷残基在激动剂诱导的AC激活中的作用。由于这些带电荷残基在所有介导AC激活的II类肽受体中绝对保守,它们可能在II类受体与Gs蛋白的偶联中起普遍作用。